Business   

Allergan opens research centre

BANGALORE: Allergan Inc., the $3.01 billion (FY 2006) U.S.-based pharmaceutical company, opened Allergan Pharmaceutical Development Centre here on Wednesday, focused on ophthalmology treatment.

It will eventually become one of the company’s largest research facilities outside the U.S.

Scott M. Whitcup, Executive Vice-President, R&D for Allergan Worldwide, told reporters that the company would spend “$2-3 million over the next two years and may double the present research staff to 15. The Bangalore centre will be critical to our research activities”.

Rman Shetty, Head-Clinical Research, India, said Allergan India in Bangalore, will continue to manage the business operations in India.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

PAN not furnished for 25 lakh demat accounts
BOA clears two SEZs of Infosys
Deutsche Bank joins hands with Lufthansa
Apollo Group floats health insurance co.
Tata Sky to invest Rs. 2,000 cr.
Rupee suffers setback
Sensex shoots up
Allergan opens research centre
Lucas TVS buys Indrad Auto Components
Correction
Pick up stake in RCoM tower business
RBI raises MSS cap
SAT stays SEBI order on Karvy
Sharp rise in Calsoft’s net profit
ING Vysya Life launches unit-linked product
Sierra Atlantic acquires U.S. firm
IFBI expands network
Nadi Airtechnics changes name

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu